Item 7.01 Regulation FD Disclosure

On March 16, 2020, the Company issued a press release covering the Panama distribution agreement with Co-Diagnostics and Health Tech Innovation Systems, Inc.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



  99.1     Press Release dated March 16, 2020





2

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 16, 2020 PreCheck Health Services, Inc.



                     By:  /s/ Justin E. Anderson
                          Justin E. Anderson
                          Chief Executive Officer





3

© Edgar Online, source Glimpses